Literature DB >> 35340077

Identification of ENPP1 Haploinsufficiency in Patients With Diffuse Idiopathic Skeletal Hyperostosis and Early-Onset Osteoporosis.

Hajime Kato1,2, Anenya J Ansh3, Ethan R Lester3, Yuka Kinoshita1,2, Naoko Hidaka1,2, Yoshitomo Hoshino1,2, Minae Koga1,2, Yuki Taniguchi4, Taisuke Uchida5, Hideki Yamaguchi5, Yo Niida6, Masamitsu Nakazato5, Masaomi Nangaku1, Noriko Makita1,2, Toshinari Takamura7, Taku Saito2,4, Demetrios T Braddock3, Nobuaki Ito1,2.   

Abstract

Homozygous ENPP1 mutations are associated with autosomal recessive hypophosphatemic rickets type 2 (ARHR2), severe ossification of the spinal ligaments, and generalized arterial calcification of infancy type 1. There are a limited number of reports on phenotypes associated with heterozygous ENPP1 mutations. Here, we report a series of three probands and their families with heterozygous and compound heterozygous ENPP1 mutations. The first case (case 1) was a 47-year-old male, diagnosed with early-onset osteoporosis and low-normal serum phosphate levels, which invoked suspicion for hypophosphatemic rickets. The second and third cases were 77- and 54-year-old females who both presented with severe spinal ligament ossification and the presumptive diagnosis of diffuse idiopathic skeletal hyperostosis (DISH). Upon workup, fibroblast growth factor 23 (FGF23) was noted to be relatively high in case 2 and serum phosphorous was low-normal in case 3, and the diagnoses of X-linked hypophosphatemic rickets (XLH) and ARHR2 were considered. Genetic testing for genes related to congenital hypophosphatemic rickets was therefore performed, revealing heterozygous ENPP1 variants in cases 1 and 2 (case 1, c.536A>G, p.Asn179Ser; case 2, c.1352A>G, p.Tyr451Cys) and compound heterozygous ENPP1 variants in case 3 constituting the same variants present in cases 1 and 2 (c.536A>G, p.Asn179Ser and c.1352A>G, p.Tyr451Cys). Several in silico tools predicted the two variants to be pathogeneic, a finding confirmed by in vitro biochemical analysis demonstrating that the p.Asn179Ser and p.Tyr451Cys ENPP1 variants possessed a catalytic velocity of 45% and 30% compared with that of wild-type ENPP1, respectively. Both variants were therefore categorized as pathogenic loss-of-function mutations. Our findings suggest that ENPP1 mutational status should be evaluated in patients presenting with the diagnosis of idiopathic DISH, ossification of the posterior longitudinal ligament (OPLL), and early-onset osteoporosis.
© 2022 American Society for Bone and Mineral Research (ASBMR). © 2022 American Society for Bone and Mineral Research (ASBMR).

Entities:  

Keywords:  DIFFUSE IDIOPATHIC SKELETAL HYPEROSTOSIS; EARLY-ONSET OSTEOPOROSIS; ENTHESOPATHY; FIBROBLAST GROWTH FACTOR 23; OSSIFICATION OF THE POSTERIOR LONGITUDINAL LIGAMENT; OSTEOPHYTE

Mesh:

Substances:

Year:  2022        PMID: 35340077      PMCID: PMC9177665          DOI: 10.1002/jbmr.4550

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.390


  52 in total

1.  MutationTaster evaluates disease-causing potential of sequence alterations.

Authors:  Jana Marie Schwarz; Christian Rödelsperger; Markus Schuelke; Dominik Seelow
Journal:  Nat Methods       Date:  2010-08       Impact factor: 28.547

2.  Association of the human NPPS gene with ossification of the posterior longitudinal ligament of the spine (OPLL).

Authors:  I Nakamura; S Ikegawa; A Okawa; S Okuda; Y Koshizuka; H Kawaguchi; K Nakamura; T Koyama; S Goto; J Toguchida; M Matsushita; T Ochi; K Takaoka; Y Nakamura
Journal:  Hum Genet       Date:  1999-06       Impact factor: 4.132

3.  Incidence of complications in 25 adult patients with X-linked hypophosphatemia.

Authors:  Hajime Kato; Minae Koga; Yuka Kinoshita; Yuki Taniguchi; Hiroshi Kobayashi; Seiji Fukumoto; Masaomi Nangaku; Noriko Makita; Nobuaki Ito
Journal:  J Clin Endocrinol Metab       Date:  2021-04-29       Impact factor: 5.958

4.  Loss-of-function ENPP1 mutations cause both generalized arterial calcification of infancy and autosomal-recessive hypophosphatemic rickets.

Authors:  Bettina Lorenz-Depiereux; Dirk Schnabel; Dov Tiosano; Gabriele Häusler; Tim M Strom
Journal:  Am J Hum Genet       Date:  2010-02-04       Impact factor: 11.025

5.  A method and server for predicting damaging missense mutations.

Authors:  Ivan A Adzhubei; Steffen Schmidt; Leonid Peshkin; Vasily E Ramensky; Anna Gerasimova; Peer Bork; Alexey S Kondrashov; Shamil R Sunyaev
Journal:  Nat Methods       Date:  2010-04       Impact factor: 28.547

6.  Mutations in a gene encoding an ABC transporter cause pseudoxanthoma elasticum.

Authors:  O Le Saux; Z Urban; C Tschuch; K Csiszar; B Bacchelli; D Quaglino; I Pasquali-Ronchetti; F M Pope; A Richards; S Terry; L Bercovitch; A de Paepe; C D Boyd
Journal:  Nat Genet       Date:  2000-06       Impact factor: 38.330

7.  Response of the ENPP1-Deficient Skeletal Phenotype to Oral Phosphate Supplementation and/or Enzyme Replacement Therapy: Comparative Studies in Humans and Mice.

Authors:  Carlos R Ferreira; Dillon Kavanagh; Ralf Oheim; Kristin Zimmerman; Julian Stürznickel; Xiaofeng Li; Paul Stabach; R Luke Rettig; Logan Calderone; Colin MacKichan; Aaron Wang; Hunter A Hutchinson; Tracy Nelson; Steven M Tommasini; Simon von Kroge; Imke Ak Fiedler; Ethan R Lester; Gilbert W Moeckel; Björn Busse; Thorsten Schinke; Thomas O Carpenter; Michael A Levine; Mark C Horowitz; Demetrios T Braddock
Journal:  J Bone Miner Res       Date:  2021-02-18       Impact factor: 6.741

8.  A Reference Range for Plasma Levels of Inorganic Pyrophosphate in Children Using the ATP Sulfurylase Method.

Authors:  Eva Bernhard; Yvonne Nitschke; Gus Khursigara; Yves Sabbagh; Yongbao Wang; Frank Rutsch
Journal:  J Clin Endocrinol Metab       Date:  2022-01-01       Impact factor: 5.958

9.  Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production.

Authors:  Valentin David; Aline Martin; Tamara Isakova; Christina Spaulding; Lixin Qi; Veronica Ramirez; Kimberly B Zumbrennen-Bullough; Chia Chi Sun; Herbert Y Lin; Jodie L Babitt; Myles Wolf
Journal:  Kidney Int       Date:  2016-01-04       Impact factor: 10.612

10.  The Tohoku Medical Megabank Project: Design and Mission.

Authors:  Shinichi Kuriyama; Nobuo Yaegashi; Fuji Nagami; Tomohiko Arai; Yoshio Kawaguchi; Noriko Osumi; Masaki Sakaida; Yoichi Suzuki; Keiko Nakayama; Hiroaki Hashizume; Gen Tamiya; Hiroshi Kawame; Kichiya Suzuki; Atsushi Hozawa; Naoki Nakaya; Masahiro Kikuya; Hirohito Metoki; Ichiro Tsuji; Nobuo Fuse; Hideyasu Kiyomoto; Junichi Sugawara; Akito Tsuboi; Shinichi Egawa; Kiyoshi Ito; Koichi Chida; Tadashi Ishii; Hiroaki Tomita; Yasuyuki Taki; Naoko Minegishi; Naoto Ishii; Jun Yasuda; Kazuhiko Igarashi; Ritsuko Shimizu; Masao Nagasaki; Seizo Koshiba; Kengo Kinoshita; Soichi Ogishima; Takako Takai-Igarashi; Teiji Tominaga; Osamu Tanabe; Noriaki Ohuchi; Toru Shimosegawa; Shigeo Kure; Hiroshi Tanaka; Sadayoshi Ito; Jiro Hitomi; Kozo Tanno; Motoyuki Nakamura; Kuniaki Ogasawara; Seiichiro Kobayashi; Kiyomi Sakata; Mamoru Satoh; Atsushi Shimizu; Makoto Sasaki; Ryujin Endo; Kenji Sobue; The Tohoku Medical Megabank Project Study Group; Masayuki Yamamoto
Journal:  J Epidemiol       Date:  2016-07-02       Impact factor: 3.211

View more
  1 in total

Review 1.  Case Report and Review of Literature: Autosomal Recessive Hypophosphatemic Rickets Type 2 Caused by a Pathogenic Variant in ENPP1 Gene.

Authors:  Yunsoo Choe; Choong Ho Shin; Young Ah Lee; Man Jin Kim; Yun Jeong Lee
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-29       Impact factor: 6.055

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.